Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Enrollment begins in pivotal phase III trials of Atrisone for acne

Nov. 8, 2002

Approvable letter for Olux expanded label

Oct. 31, 2002

Second Allox phase I/II trial completed

Oct. 30, 2002

Pilot study of the humanized anti-C5 monoclonal antibody eculizumab in dermatomyositis

Oct. 29, 2002

New C5a and/or IL-8 antagonists identified by Dompe researchers

Oct. 24, 2002

GSK describes new IL-8 antagonists and their use in psoriasis, arthritis, etc.

Oct. 24, 2002

Potential use of two novel PDE4 inhibitors in allergic dermatitis

Oct. 24, 2002

Alefacept reported to be a valid therapeutic option for chronic psoriasis

Oct. 21, 2002

New data on the safety and efficacy of topical tacrolimus in atopic dermatitis

Oct. 21, 2002

Scientists at Ajinomoto synthesize inhibitors of activation of inflammatory factors

Oct. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...